Activating NO–sGC Crosstalk in the Mouse Vascular Niche Promotes Vascular Integrity and Mitigates Acute Lung Injury
Hao He,Wu Yang,Nan Su,Chuankai Zhang,Jianing Dai,Feng Han,Mahak Singhal,Wenjuan Bai,Xiaolan Zhu,Jing Zhu,Zhen Liu,Wencheng Xia,Xiaoting Liu,Chonghe Zhang,Kai Jiang,Wenhui Huang,Dan Chen,Zhaoyin Wang,Xueyang He,Frank Kirchhoff,Zhenyu Li,Cong Liu,Jingning Huan,Xiaohong Wang,Wu Wei,Jing Wang,Hellmut G Augustin,Junhao Hu
DOI: https://doi.org/10.1084/jem.20211422
2022-01-01
The Journal of Experimental Medicine
Abstract:Disruption of endothelial cell (ECs) and pericytes interactions results in vascular leakage in acute lung injury (ALI). However, molecular signals mediating EC–pericyte crosstalk have not been systemically investigated, and whether targeting such crosstalk could be adopted to combat ALI remains elusive. Using comparative genome-wide EC–pericyte crosstalk analysis of healthy and LPS-challenged lungs, we discovered that crosstalk between endothelial nitric oxide and pericyte soluble guanylate cyclase (NO–sGC) is impaired in ALI. Indeed, stimulating the NO–sGC pathway promotes vascular integrity and reduces lung edema and inflammation-induced lung injury, while pericyte-specific sGC knockout abolishes this protective effect. Mechanistically, sGC activation suppresses cytoskeleton rearrangement in pericytes through inhibiting VASP-dependent F-actin formation and MRTFA/SRF-dependent de novo synthesis of genes associated with cytoskeleton rearrangement, thereby leading to the stabilization of EC–pericyte interactions. Collectively, our data demonstrate that impaired NO–sGC crosstalk in the vascular niche results in elevated vascular permeability, and pharmacological activation of this crosstalk represents a promising translational therapy for ALI.